Christina Lingham’s Post

Please find the fascination of our SMab platform for antibody discovery and experience the The magic of antibody engineering. By watch this video presented by our CSO Dr. Hao Cheng. https://lnkd.in/gjimNF_z #antibodydiscovery #antibodytherapeutics #antibodyengineering #antibody

🔬 Join Proteintech Group upcoming webinar on addressing the reproducibility crisis and advancing research through effective antibody characterization!🧪 Riham Ayoubi, Director of Operations at the YCharOS project, will share her expertise and practical tips for ensuring the #reliability and #reproducibility of your research. 📅 Register now: https://lnkd.in/e-KvND9v In this webinar, Dr. Ayoubi will cover: *The critical role of antibody characterization in overcoming reproducibility challenges. *YCharOS’s mission and platform for enhancing antibody validation. *Best practices and conditions for characterization in applications such as #westernblot, #immunoprecipitation, and #immunofluorescence. *Key challenges and limitations faced in #antibody characterization. Don’t miss this opportunity to learn from a leading expert and improve the reproducibility of your research.

In this short movie, you can clearly observe the microstreaming flow around the microbubbles. I invite you to watch and listen carefully. 🎤Presenter: Professor Ayache Bouakaz ⏱️In Scientific session Non-ionising radiation: Ultrasound-mediated drug delivery Title: Recent advances in ultrasound-mediated drug delivery: Insights from preclinical and clinical trials. #MicrostreamingFlow #Microbubbles #UltrasoundMechanics #DrugDelivery #ScientificSession #UltrasoundResearch #ClinicalTrials

We're at SLAS! See our first poster presentation at 2pm EST and speak to one of the lead authors Dr Sian Humphreys. At 2pm EST today (Track: Cellular Technologies, poster session B) we're presenting our first SLAS poster titled "Differentiation of multiple iPSC lines to different cell types to enable cohort analysis in neurodegeneration: challenges and learnings". Tomorrow at 10am EST, we'll also be joined by our friends from Axion BioSystems at our booth (#224) to discuss iPSC technology, MEA, QC and phenotyping of advanced in vitro models. #iPSCs #SLAS #biotech #StemCells #DrugDiscovery

A fantastic series about high throughput screening strategies. #drughunting #MedicinalChemistry #ResearchNeverStops #Evotec #discovery #development #manufacturing #DMPK #drugdiscovery #pharma ADME #Toxicology #biotech #lifesciences #RnD #oncology #cancer #alzheimersdisease #immunology #cardiovascular #inflammation #CNS #neurodegeneration #infectiousdiseases #autoimmunedisease #cellandgenetherapy #iPSCs #proteomics #degraders #genetics #stratification #personalization

Curious to learn about hit identification and high throughput screening strategies at Evotec? Join our 5-part webinar series now. The first 3 episodes are already available on demand, while new episodes in September and October are open for registration now. Overview of the episodes: #1: Unlocking High Throughput Hit Identification Strategies, with Thomas Ahrens #2: It All Starts With a Protein – Protein Sciences as a Key to Success in Drug Discovery, with James Errey #3: Molecular Interactions Matter - Biophysical Screening for Early Drug Discovery, with Florian Krieger #4: The Role of Structural Insights in Drug Discovery, with Jay Bertrand #5: Illuminating Cellular Processes through High Content Methods, with Karsten Kottig and Sven Schreiter To find more information, and to get access to the individual sessions, please visit: https://hubs.ly/Q02H5HRr0 #researchneverstops #Evotec #drugdiscovery

Join our 𝐅𝐑𝐄𝐄 webinar delving into the shift towards animal-free models with experts Aline Miller, Darius Widera, Dominik Egger, and Tamara Zietek! ✨ 📆 Wednesday 17th April 2024 🕓 14:00 BST | 09:00 EDT 🖥️ Register here: https://hubs.la/Q02sxk800 𝐃𝐢𝐬𝐜𝐮𝐬𝐬𝐢𝐨𝐧 𝐭𝐨𝐩𝐢𝐜𝐬 𝐢𝐧𝐜𝐥𝐮𝐝𝐞: ✔️ Innovations in synthetic hydrogel scaffolds and growth factors ✔️ Exploring the ethical and scientific benefits of animal-free 3D cell culture models ✔️ Applications in regenerative medicine and drug discovery #OGCell #3DCellCulture #DrugDiscovery

👨🔬 Meet Frank our group leader in assay development 👋 👔 This week, Frank represented Sphere Fluidics not only with his super on-brand shirt colour, but also with his audience captivating poster presentation at the Immuno-Oncology Summit Europe 2024, held in London! 💧 The poster titled; "Picodroplets For Cell Line Development & Antibody Discovery, Accelerating The Discovery And Development Process" explores why picodroplets are at the core of our Cyto-Mine® platform. And how high-throughput can be easily achieved using our technology to process up to 40 million heterogeneous mammalian cells (in pools) in less than a day! 💡 Find out more about our picodroplet technology: https://bit.ly/44oq7qk 🔎 Discover our upcoming events: https://rb.gy/zr6ppk #IOSummitUK #celllinedevelopment #microfluidics #drugdiscovery #biotech

Join our 𝐅𝐑𝐄𝐄 webinar delving into the shift towards animal-free models with experts Aline Miller, Darius Widera, Dominik Egger, and Tamara Zietek! ✨ 📆 Wednesday 17th April 2024 🕓 14:00 BST | 09:00 EDT 🖥️ Register here: https://hubs.la/Q02sxhyZ0 𝐃𝐢𝐬𝐜𝐮𝐬𝐬𝐢𝐨𝐧 𝐭𝐨𝐩𝐢𝐜𝐬 𝐢𝐧𝐜𝐥𝐮𝐝𝐞: ✔️ Innovations in synthetic hydrogel scaffolds and growth factors ✔️ Exploring the ethical and scientific benefits of animal-free 3D cell culture models ✔️ Applications in regenerative medicine and drug discovery #OGCell #3DCellCulture #DrugDiscovery

Interested in RNA-targeted drug development? RNA is a largely unexplored drug target offering a promising new approach to treating many diseases with unmet medical need. But current analytical methods for investigating RNA-drug interactions have significant limitations. They struggle to accurately measure the dynamic interactions between small molecules and their target RNAs, and provide little to no information on binding kinetics. Our revolutionary new technology, MAGNA™, changes the game. Based on magnetic force spectroscopy, MAGNA provides real-time and comprehensive measurements of individual molecular interactions at scale. With MAGNA, you can: - Measure individual RNA-ligand interactions - Reveal mechanisms of action - Determine ligand effects on the stability and activity of RNA structures - And more! See MAGNA in action. Watch the full video on YouTube https://lnkd.in/ea9XmxQf or check out the sneak peek clip below. Like what you see? 👀 Our early adopter programme has now launched, bringing the transformative power of MAGNA direct to the global R&D community. Join the club - get in touch with the team at info@depixus.com to learn more and secure your spot. Animation in video courtesy of Freudenfeld Design Ltd, animation by Richard Freudenfeld #RNATherapeutics #DrugDiscovery #Biotech #interactomics #Depixus